Chemomab Therapeutics (CMMB) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Chemomab Therapeutics Ltd. has released its unaudited interim condensed consolidated financial statements for the period ending June 30, 2024. The statements show a decrease in total current assets from the previous year-end, with figures moving from $20,897 thousand to $13,455 thousand. The report also details changes in liabilities, including trade payables and accrued expenses.
For further insights into CMMB stock, check out TipRanks’ Stock Analysis page.